CGI Pharmaceuticals is a startup, most recent round Acquired.
CGI Pharmaceuticals is a startup. CGI Pharmaceuticals has been acquired.
CGI Pharmaceuticals was a development-stage biotechnology company founded in 2001 that discovered and developed small-molecule kinase inhibitors targeting oncology, angiogenesis, and autoimmune, allergic and inflammatory diseases. The company was acquired by Gilead Sciences in 2010 for $120M.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.